Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.
about
Decision aids for people facing health treatment or screening decisionsCancer genetic risk assessment for individuals at risk of familial breast cancerDecision aids for people facing health treatment or screening decisionsWhat is lacking in current decision aids on cancer screening?Decision aids for people facing health treatment or screening decisionsAll your data (effectively) belong to us: data practices among direct-to-consumer genetic testing firms.Risky feelings: why a 6% risk of cancer does not always feel like 6%Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers.Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers.Public understanding of risks from gene-environment interaction in common diseases: implications for public communications.Direct-to-consumer genomic testing: systematic review of the literature on user perspectives.Update on Direct-to-Consumer Marketing in Oncology.The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.Predictors of interest in direct-to-consumer genetic testing.Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation.Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK.
P2860
Q24200969-7BA9C851-9A56-4629-9BB3-237F91C6EE84Q24203650-525DD9A7-7F8E-4AEF-B364-11165C22AAF6Q24235817-9BA8F857-3BEB-485E-8E3E-29BA7ED97A51Q26822925-7A2800F6-DA4E-45C2-836F-16DDCFFD1965Q29994603-29C87671-0EFB-4403-877F-DF8D8A34D64AQ31132459-F0242E44-1255-4B60-851E-66F0FECF4306Q34361319-EA14947B-AB9F-417B-9A60-A0C48AEAEF2DQ34379754-A0DD36E2-2A71-4BE8-A97A-30608ABB23DEQ34636079-D2B2CF82-1054-4881-9860-B5BB9FA18EF4Q35546418-F740A78C-DC55-49A8-9E41-448487AF83C6Q36105198-482F77C1-2172-4488-8354-DF80E8B54ED6Q36278400-59681C3F-2E23-4396-ACCC-3C58C881E1F8Q37355229-7B3A16BD-4F17-48D8-86A9-576EEF61A615Q46521298-1C177CFF-3FA4-4C30-82FA-E103E637E4AEQ46621012-1978C007-CEB0-43A9-80EC-4541923505E6Q47185863-A94D11DF-034B-4953-8B2F-21A0B5243988
P2860
Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Risk information exposure and ...... y of breast or ovarian cancer.
@ast
Risk information exposure and ...... y of breast or ovarian cancer.
@en
Risk information exposure and ...... y of breast or ovarian cancer.
@nl
type
label
Risk information exposure and ...... y of breast or ovarian cancer.
@ast
Risk information exposure and ...... y of breast or ovarian cancer.
@en
Risk information exposure and ...... y of breast or ovarian cancer.
@nl
prefLabel
Risk information exposure and ...... y of breast or ovarian cancer.
@ast
Risk information exposure and ...... y of breast or ovarian cancer.
@en
Risk information exposure and ...... y of breast or ovarian cancer.
@nl
P2093
P2860
P1476
Risk information exposure and ...... ry of breast or ovarian cancer
@en
P2093
Cristin O'Grady
Daniel Smith
J Sanford Schwartz
Katrina Armstrong
Lauren Karp
Stacy W Gray
P2860
P304
P356
10.1158/1055-9965.EPI-08-0825
P577
2009-03-24T00:00:00Z